Skip to content

Yoga program on COVID 19 patients

Effect of an integrated Yoga program on stress, mood states, sleep quality, symptom severity, quality of life and clinical outcomes in Covid19 positive patients undergoing conventional treatment : a Multicentric trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028827
Enrollment
86
Registered
2020-11-03
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

Intervention1: Test Group: Integrated biofeedback based yoga program Covid 19 patients take part in a 2 week Integrated biofeedback based yoga program following admission to a tertiary Covid 19 screen

Sponsors

Central Council for Research in Yoga and Naturopathy Ministry of AYUSH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Covid 19 positive case diagnosed using RT PCR in authorized Covid19 testing facility 2.Mild clinical presentation (identified at the time of admission to ward by National Early Warning Score NEWS-2; mild 0-4; severe 5-6) 3.Presenting with or without flu symptoms 4.Aged 18-60 years 5.High school education 6.Written consent to participate in any arm of the study 7.Those having a smart phone mobile device with android or IOS operating system.

Exclusion criteria

Exclusion criteria: 1.Severe infection News-3-4 requiring admission to ICU. 2.Unable to take oral medication, 3.Immunocompromised, 4.Creatinine clearance (CCL) 5.Aspartate transaminase (AST) or alanine transaminase (ALT) > 5 times Upper limit of normal (ULN), 6.d-dimer > 2microgram per liter, or 7.Uncontrolled diabetes, Hypertension, Existing Heart disease and heart failure, any cancer, autoimmune disease, stroke, neurodegenerative diseases etc.. 8.Clinical condition that reduces survival to less than six months. 9.Pregnancy and lactating mothers 10.Clinical signs suggestive of septicemia and multi organ dysfunction. 11. Score of less than 24 points on the Folstein Mini-Mental State Examination(43). 12.Score of more than 14 points on the 9-item Patient Health Questionnaire (PHQ-9) depression screen (44). 13.BMI less than 18

Design outcomes

Primary

MeasureTime frame
The primary outcome will be defined as area-under-the curve global severity for all ARI illness days throughout observation, from consent to study exitTimepoint: Day 0 to study exit

Secondary

MeasureTime frame
1. Time to discharge/recovery: Discharge/recovery, ICU admissions and Death will be considered events. Time to event analysis will be carried out as one of the outcomes. Will be a study endpoint. 2. Biomarkers: With each ARI illness episode, a nasal wash /throat swab will be collected in VTB medium within 3 days of symptom onset and analyzed for covid 19 using Multiplex polymerase chain reaction (PCR) This test will be done at baseline and 14 days. Timepoint: Day 0 and Day 14

Countries

India

Contacts

Public ContactDr Raghavendra Rao M

Central Council for Research in Yoga & Naturopathy (CCRYN)

ccryn.director@gmail.com9916488864

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026